PMGC Holdings Inc. ELAB
Regular-session close
After hours · Nov 20, 7:09 PM ET
- YTD
- -99.68%
- 1 year
- -99.90%
5D -0.29 (-18.35%)
- Market cap
- 1.33M
- Revenue (ttm)
- 2.47M
- Profit margin
- -192.08%
- EPS (ttm)
- -555.60
- Shares out
- 3.07M
- YTD return
- -99.68%
- 1-year return
- -99.90%
- Volume
- 68.50K
- Avg volume
- 281.10K
- Open
- 1.29
- Previous close
- 1.27
- Day's range
- 1.14 – 1.35
- 52-week range
- 1.14 – 1,291.20
- 50-day average
- 7.79
Key statistics
- 200-day average
- 77.01
- Enterprise value
- 569.06K
- Price / sales
- 3.24
- Price / book
- 11.81
- Revenue growth
- 91.30%
- Free cash flow
- -3.57M
- Total cash
- 100.03K
- Total debt
- 140.06K
- Return on equity
- -351.00%
- Short % of float
- 22.28%
Fundamental scorecard
6 of 25 checks passed on ELAB’s reported financials
6of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 1 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
About PMGC Holdings Inc.
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- elevaiskincare.com
News
NorthStrive Defense Tech Announces Successful Completion of Technical Validation and Update to Acquire GPS-Denied Drone Navigation Technology
PMGC Holdings Inc. [NASDAQ: ELAB] Announces Successful Combination of Two Aerospace Manufacturing Companies into a Single California Location, Enhancing Manufacturing and Operational Efficiency and Reducing Costs
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Record Q3 Revenue, Up 785% Year-over-Year to $2.53 Million and Up 94% From Previous Quarter; Files Form 10-Q for Q3 2026; Total Assets of $133.1 Million Include $100.4 Million Held in Trust by Sponsored SPAC PMGC Holdings Completes Subscription For Common Shares In Orbit2Orbit; Financial Terms Not Disclosed
PMGC Holdings Unit Northstrive Biosciences Completes Preclinical Study Evaluating EL-32 Both As A Standalone Treatment And In Combination With Semaglutide; Study Identifies Preliminary Lean-mass Finding At Highest Dose While Informing Future Preclinical Development Strategy
Your note
Sign in to keep a note on ELAB — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sabby Management, LLC | 0.00% | 12,709 | 33.17K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.00% | 226 | 589 | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.00% | 216 | 563 | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.00% | 196 | 511 | Sep 29, 2024 |
| HRT Financial LP | 0.00% | 179 | 467 | Sep 29, 2024 |
| Diversify Advisory Services, LLC | 0.00% | 125 | 326 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.00% | 226 | 589 | Oct 30, 2024 |
